HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel S Greenspan Selected Research

Collagen Type V (Type V Collagen)

3/2013IL-17 induces type V collagen overexpression and EMT via TGF-β-dependent pathways in obliterative bronchiolitis.
11/2012Comprehensive mass spectrometric mapping of the hydroxylated amino acid residues of the α1(V) collagen chain.
10/2010Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis.
8/2010Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome.
10/2008Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction.
3/2008Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.
11/2007IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel S Greenspan Research Topics

Disease

4Bronchiolitis
03/2013 - 11/2007
3Osteogenesis Imperfecta (Lobstein Disease)
01/2021 - 06/2014
3Atherosclerosis
02/2016 - 10/2010
2Atherosclerotic Plaque (Atheroma)
02/2016 - 10/2010
2Coronary Artery Disease (Coronary Atherosclerosis)
02/2016 - 10/2010
2Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
11/2012 - 05/2003
2Fibrosis (Cirrhosis)
01/2009 - 12/2006
2Primary Graft Dysfunction
10/2008 - 03/2008
1Alveolar Bone Loss
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Corneal Opacity
12/2017
1Cicatrix (Scar)
12/2017
1Burns
12/2017
1Corneal Injuries
12/2017
1Breast Neoplasms (Breast Cancer)
01/2017
1Dentinogenesis Imperfecta
01/2017
1Osteomalacia
06/2014
1Disease Progression
10/2010
1Idiopathic Pulmonary Fibrosis
08/2010
1Bronchiolitis Obliterans Syndrome
08/2010
1Gastroesophageal Reflux (GERD)
08/2010
1Myocardial Infarction
01/2009
1Acromicric dysplasia
09/2008
1Lung Diseases (Lung Disease)
03/2008
1Hypersensitivity (Allergy)
03/2008
1Vasculitis (Vasculitides)
03/2008
1Neoplasms (Cancer)
06/2007
1Chronic Kidney Failure (Chronic Renal Failure)
02/2005
1Premature Rupture Fetal Membranes
02/2005
1Autosomal Recessive Type VII Ehlers-Danlos Syndrome
05/2003
1Osteosarcoma (Osteogenic Sarcoma)
05/2003
1Open-Angle Glaucoma (Glaucoma, Open Angle)
12/2002
1Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
07/2002

Drug/Important Bio-Agent (IBA)

7Collagen Type V (Type V Collagen)IBA
03/2013 - 11/2007
5Peptide Hydrolases (Proteases)FDA Link
01/2021 - 05/2003
5ProcollagenIBA
12/2017 - 07/2002
3CollagenIBA
12/2017 - 06/2014
3Proteins (Proteins, Gene)FDA Link
06/2014 - 12/2002
2InterleukinsIBA
02/2016 - 10/2010
2Apolipoproteins E (ApoE)IBA
02/2016 - 10/2010
2Prostaglandins DIBA
10/2008 - 03/2008
2Metalloproteases (Metalloproteinases)IBA
09/2008 - 05/2003
2Messenger RNA (mRNA)IBA
06/2007 - 05/2003
1Bone Morphogenetic Protein 1IBA
01/2021
1LDL CholesterolIBA
01/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2019
1Fibrillar CollagensIBA
12/2017
1AlkaliesIBA
12/2017
1GlypicansIBA
01/2017
1Phenobarbital (Luminal)FDA Link
01/2017
1alpha2 Subunit Collagen Type IIBA
06/2014
1Interleukin-17 (Interleukin 17)IBA
03/2013
1ApolipoproteinsIBA
10/2010
1AutoantigensIBA
10/2010
1WD repeat containing planar cell polarity effectorIBA
01/2009
1Glycoproteins (Glycoprotein)IBA
09/2008
1DisintegrinsIBA
09/2008
1ThrombospondinsIBA
09/2008
1ADAMTS ProteinsIBA
09/2008
1Latent TGF-beta Binding Proteins (Latent TGF beta Binding Protein)IBA
09/2008
1Transforming Growth Factor beta (TGF-beta)IBA
09/2008
1MonokinesIBA
03/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008
1Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2003
1Collagen Type III (Type III Collagen)IBA
05/2003
1EnzymesIBA
05/2003
1Cycloheximide (Cicloheximide)IBA
05/2003

Therapy/Procedure

4Lung Transplantation
03/2013 - 03/2008
1Mucosal Administration
02/2016